home / stock / ziop / ziop short
Short Information | ZIOPHARM Oncology Inc (NASDAQ:ZIOP)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 6,777,696 |
Total Actual Volume | 49,672,610 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 338,885 |
Average Short Percentage | 14.85% |
Is there a ZIOP Short Squeeze or Breakout about to happen?
See the ZIOP Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
01-26-2022 | $0.91 | $0.8657 | $0.97 | $0.8611 | 2,127,346 | 537,338 | 25.26% |
01-25-2022 | $0.9314 | $0.8734 | $0.9314 | $0.8401 | 1,723,613 | 294,843 | 17.11% |
01-24-2022 | $0.8006 | $0.9191 | $0.9399 | $0.7703 | 2,186,311 | 359,410 | 16.44% |
01-12-2022 | $1 | $0.9449 | $1.01 | $0.9401 | 1,866,682 | 185,070 | 9.91% |
01-11-2022 | $0.99 | $1 | $1.065 | $0.9801 | 1,215,606 | 357,607 | 29.42% |
01-10-2022 | $1 | $0.9857 | $1.005 | $0.932 | 1,570,322 | 199,080 | 12.68% |
01-07-2022 | $1 | $0.9955 | $1.05 | $0.9901 | 1,022,067 | 209,933 | 20.54% |
01-06-2022 | $1.02 | $1.02 | $1.055 | $0.9877 | 2,242,379 | 385,272 | 17.18% |
01-05-2022 | $1.1 | $1.01 | $1.135 | $1.01 | 2,997,932 | 490,189 | 16.35% |
01-04-2022 | $1.17 | $1.09 | $1.18 | $1.09 | 2,636,352 | 271,208 | 10.29% |
01-03-2022 | $1.09 | $1.17 | $1.18 | $1.085 | 1,888,218 | 275,374 | 14.58% |
12-30-2021 | $1.1 | $1.12 | $1.21 | $1.0704 | 2,629,438 | 435,418 | 16.56% |
12-29-2021 | $1.11 | $1.09 | $1.13 | $1.08 | 2,210,396 | 292,081 | 13.21% |
12-28-2021 | $1.18 | $1.11 | $1.19 | $1.11 | 2,253,075 | 366,000 | 16.24% |
12-22-2021 | $1.28 | $1.27 | $1.33 | $1.25 | 2,653,966 | 227,856 | 8.59% |
12-21-2021 | $1.29 | $1.32 | $1.34 | $1.24 | 2,808,244 | 219,330 | 7.81% |
12-20-2021 | $1.28 | $1.28 | $1.32 | $1.22 | 2,135,330 | 137,473 | 6.44% |
12-17-2021 | $1.19 | $1.35 | $1.38 | $1.17 | 5,373,899 | 337,311 | 6.28% |
12-15-2021 | $1.17 | $1.26 | $1.26 | $1.12 | 5,224,765 | 593,584 | 11.36% |
12-14-2021 | $1.18 | $1.18 | $1.22 | $1.15 | 2,906,669 | 603,319 | 20.76% |
News, Short Squeeze, Breakout and More Instantly...
ZIOPHARM Oncology Inc Company Name:
ZIOP Stock Symbol:
NASDAQ Market:
ZIOPHARM Oncology Inc Website:
TCR-T Library Phase 1/2 trial achieved an 87% disease control rate of eight evaluable patients with metastatic, refractory solid tumors; TCR-T cell therapy was well tolerated in all treated patients hunTR® discovered new HLA class I and class II restricted TCRs that recognize d...
TCR-T Library Phase 1/2 trial achieved an 83% disease control rate of six evaluable patients with metastatic, refractory solid tumors; TCR-T cell therapy was well tolerated in all evaluable patients Company to wind down TCR-T Library Phase 1/2 trial and concurrently explore potent...
HOUSTON, June 29, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a leading T-cell receptor (TCR) cell therapy company advancing a clinical-stage pipeline of therapeutics for solid tumors, today announced that the Compan...